Views & Analysis Adding value to generics and biosimilars Paul Tredwell, vice president for specialty brands at Accord Healthcare says innovation is vital for success in today’s generics and biosimilars market.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.